Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
18F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy.
Carles M, Fechter T, Grosu AL, Sörensen A, Thomann B, Stoian RG, Wiedenmann N, Rühle A, Zamboglou C, Ruf J, Martí-Bonmatí L, Baltas D, Mix M, Nicolay NH. Carles M, et al. Among authors: wiedenmann n. Cancers (Basel). 2021 Jul 9;13(14):3449. doi: 10.3390/cancers13143449. Cancers (Basel). 2021. PMID: 34298663 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 34700599
Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy-results from a prospective trial.
Nicolay NH, Wiedenmann N, Mix M, Weber WA, Werner M, Grosu AL, Kayser G. Nicolay NH, et al. Among authors: wiedenmann n. Eur J Nucl Med Mol Imaging. 2020 May;47(5):1046-1055. doi: 10.1007/s00259-019-04598-9. Epub 2019 Dec 7. Eur J Nucl Med Mol Imaging. 2020. PMID: 31811344 Clinical Trial.
Hypoxia dynamics on FMISO-PET in combination with PD-1/PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing Chemoradiation.
Rühle A, Grosu AL, Wiedenmann N, Mix M, Stoian R, Niedermann G, Baltas D, Werner M, Weber WA, Kayser G, Nicolay NH. Rühle A, et al. Among authors: wiedenmann n. Theranostics. 2020 Jul 23;10(20):9395-9406. doi: 10.7150/thno.48392. eCollection 2020. Theranostics. 2020. PMID: 32802199 Free PMC article. Clinical Trial.
The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer.
Wiedenmann N, Grosu AL, Büchert M, Rischke HC, Ruf J, Bielak L, Majerus L, Rühle A, Bamberg F, Baltas D, Hennig J, Mix M, Bock M, Nicolay NH. Wiedenmann N, et al. Radiother Oncol. 2020 Sep;150:128-135. doi: 10.1016/j.radonc.2020.06.013. Epub 2020 Jun 13. Radiother Oncol. 2020. PMID: 32544609
Lymphocyte Infiltration Determines the Hypoxia-Dependent Response to Definitive Chemoradiation in Head-and-Neck Cancer: Results from a Prospective Imaging Trial.
Nicolay NH, Rühle A, Wiedenmann N, Niedermann G, Mix M, Weber WA, Baltas D, Werner M, Kayser G, Grosu AL. Nicolay NH, et al. Among authors: wiedenmann n. J Nucl Med. 2021 Apr;62(4):471-478. doi: 10.2967/jnumed.120.248633. Epub 2020 Aug 28. J Nucl Med. 2021. PMID: 32859699 Free PMC article. Clinical Trial.
39 results